Huynh TJ, Demchuk AM, Dowlatshahi D, Gladstone DJ, Krischek O, Kiss A, Hill MD, Molina CA, Rodriguez-Luna D, Dzialowski I, Silva Y, Czlonkowska A, Lum C, Boulanger JM, Gubitz G, Bhatia R, Padma V, Roy J, Kase CS, Aviv RI
Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study.
Partemi, S, Cestèle, S, Pezzella, M, Campuzano, O, Paravidino, R, Pascali, VL, Zara, F, Tassinari, CA, Striano, S, Oliva, A, Brugada, R, Mantegazza, M, Striano, P
Loss-of-function <i>KCNH2</i> mutation in a family with long QT syndrome, epilepsy, and sudden death
Conde-Sala JL, Garre-Olmo J, Vilalta-Franch J, Llinàs-Reglà J, Turró-Garriga O, Lozano-Gallego M, Hernández-Ferrándiz M, Pericot-Nierga I, López-Pousa S
Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
Fernández-Cadenas I, Del Río-Espínola A, Giralt D, Domingues-Montanari S, Quiroga A, Mendióroz M, Ruíz A, Ribó M, Serena J, Obach V, Freijo MM, Martí-Fábregas J, Delgado P, Montaner J
IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.
Zabalza M, Subirana I, Sala J, Lluis-Ganella C, Lucas G, Tomás M, Masiá R, Marrugat J, Brugada R, Elosua R
Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel.
Calvó-Perxas L, López-Pousa S, Vilalta-Franch J, Turró-Garriga O, Blankenburg M, Febrer L, Flaqué M, Vallmajó N, Aguirregomozcorta M, Genís D, Casas I, Perkal H, Coromina J, Garre-Olmo J
Central nervous system drug consumption depending on the time between symptom onset and the diagnosis of Alzheimer's disease: an analysis by the Registry of Dementias of Girona.
